Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

Health technology assessment (HTA) agency NICE has published final draft guidance for IL-23 inhibitor Omvoh (mirikizumab), ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...

Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...

Biogen has been trying to build up its R&D pipeline as it faces increased competition for its biggest-selling products like ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...